BenedettiJ, ZehJ, SelkeS, CoreyL. Frequency and reactivation of nongenital recurrences among patients with genital herpes simplex virus.Am J Med1995; 98: 23742
2.
MertzGJ, BemedettoJ, AshleyR, SelkeSA, CoreyL. Risk factors for the sexual transmission of genital herpes.Ann Intern Med1992; 116: 197202
3.
BrownZA, SelkeS, ZehJThe acquisition of herpes simplex virus during pregnancy.N Engl J Med1997; 337: 50915
4.
BenedettiJ, CoreyL, AshleyR. Recurrence rates in genital herpes after symptomatic first-episode infection.Ann Intern Med1994; 121: 84754
5.
FifeKH, CoreyL. Herpes simplex virus. In: HolmesKK, ed. Sexually Transmitted Diseases, 2nd edn, Chap 77. New York: McGraw-Hill, 1990: 94152
6.
ConeRW, SwensonPD, HobsonACHerpes simplex virus detection from genital lesions; a comparative study using antigen detection (HerpChek) and culture.J Clin Microbiol1993; 31: 17746
7.
KudesiaG, Van HeganA, WakeSComparison of cell culture with an amplified enzyme immunoassay for diagnosing genital herpes simplex infection.J Clin Pathol1991; 44: 77880
8.
MundayPE, VuddamalayJ, SlomkaMJ, BrownDW. Role of type specific herpes simplex virus serology in the diagnosis and management of genital herpes.Sex Transm Infect74: 1758
9.
CoreyL, BenedettiJ, CritchlowCTreatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy.J Antimicrob Chemother1983; 12 (suppl B): 7988
10.
FifeKH, BarbarashRA, RudolphT, DegregorioB, RothR. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group.Sex Transm Dis1997; 24: 4816
11.
CoreyL, MindelA, FifeKH, SutherlandS, BenedettiJ, AdlerMW. Risk of recurrence after treatment of first-episode genital herpes with intravenous acyclovir.Sex Transm Dis1985; 12: 21518
12.
NilsenAE, AasenT, HalosAMEfficacy of oral acyclovir in the treatment of initial and recurrent genital herpes.Lancet1982; ii: 5713
13.
SpruanceSL, TyringSK, DeGregoriaB, MilerC, BeutnerK and the Valaciclovir study group. A large-scale, placebo controlled, dose ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis.Arch Intern Med1996; 156: 172935
14.
SacksSL, AokiFY, Diaz-MitomaF, SellorsJ, ShafranSD, for the Canadian Famiciclovir Study. Patient-initiated, twice daily oral famciclovir for early recurrent genital herpes: a randomized, double-blind multicenter trial.JAMA1996; 276: 449
15.
PatelR, BodsworthNJ, WooleyP, and the International Valaciclovir HSV Study Group. Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy.Genitourin Med1997; 73: 1059
16.
MertzGJ, JonesCC, MillsJLong-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial.JAMA1988; 260: 2016
17.
MertzGJ, LovelessMO, LevinMJOral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.Arch Intern Med1997; 157: 3439
18.
WaldA, ZehJ, BarnumG, DavisLG, CoreyL. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.Ann Intern Med1996; 124: 815
19.
KoelleDM, BenedettiJ, LangenbergA, CoreyL. Asymptomatic reactivation of Herpes simplex virus in women after the first episode of genital herpes.Ann Intern Med1992; 116: 4337
20.
BalfourHHJR., BensonC, BraunJManagement of acyclovir-resistant herpes simplex and varicella-zoster virus infections.J Acquir Immun Defic Syndr1994; 7: 25460
21.
LalezariJ, SchackerT, FeinbergJA randomised double blind placebo controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.J Infect Dis1997; 176: 8928
22.
MertzGJ, SchmidtO, JourdanJLFrequency of acquisition of first episode genital infection with herpes simplex virus infection from symptomatic and asymptomatic source contacts.Sex Transm Dis1985; 12: 339
23.
LangenbergA, BenedettiJ, JenkinsJ, AhleyR, WinterJ, CoreyL. Development of clinically recognizable genital lesions among women previously identified as having ‘asymptomatic’ herpes simplex virus type 2 infection.Ann Intern Med1989; 110: 8827
24.
ScottLL, SanchezPJ, JacksonGL, ZerayF, WendelGD. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes.Obsetet Gynecol1996; 87: 6973
25.
ProberCG, HensleighPA, BoucherFD, YasukawaLL, AuDA, ArvinA. Use of routine viral cultures at delivery to identify neonates exposed to herpes simplex virus.N Engl J Med1988; 318: 88791
26.
ProberCG, SullenderWM, YasukawaLL, AuDA, YeagerAE, ArvinA. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes.N Engl J Med1987; 316: 2404
